129 related articles for article (PubMed ID: 21159249)
1. [Expression and its clinical significance of eIF4E in non-small cell lung cancer].
ZHANG B; ZHU C; CHEN B; ZHANG X; YE M; LIN A
Zhongguo Fei Ai Za Zhi; 2010 Dec; 13(12):1132-5. PubMed ID: 21159249
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer.
Lu J; Zang H; Zheng H; Zhan Y; Yang Y; Zhang Y; Liu S; Feng J; Wen Q; Long M; Fan S
PLoS One; 2020; 15(2):e0227768. PubMed ID: 32023262
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer.
Yoshizawa A; Fukuoka J; Shimizu S; Shilo K; Franks TJ; Hewitt SM; Fujii T; Cordon-Cardo C; Jen J; Travis WD
Clin Cancer Res; 2010 Jan; 16(1):240-8. PubMed ID: 20008839
[TBL] [Abstract][Full Text] [Related]
5. Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer.
Khoury T; Alrawi S; Ramnath N; Li Q; Grimm M; Black J; Tan D
Clin Lung Cancer; 2009 Jan; 10(1):58-66. PubMed ID: 19289374
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Derived Exosomal eIF4E as a Biomarker for Survival Prediction in Patients with Non-Small Cell Lung Cancer.
Dong Q; Dong L; Liu S; Kong Y; Zhang M; Wang X
Med Sci Monit; 2020 Jun; 26():e923210. PubMed ID: 32502142
[TBL] [Abstract][Full Text] [Related]
7. Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma.
Wang XL; Cai HP; Ge JH; Su XF
World J Gastroenterol; 2012 May; 18(20):2540-4. PubMed ID: 22654452
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues.
Fan S; Ramalingam SS; Kauh J; Xu Z; Khuri FR; Sun SY
Cancer Biol Ther; 2009 Aug; 8(15):1463-9. PubMed ID: 19483468
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p-4EBP1 associates with p-eIF4E and predicts poor prognosis for non-small cell lung cancer patients with resection.
Tang Y; Luo J; Yang Y; Liu S; Zheng H; Zhan Y; Fan S; Wen Q
PLoS One; 2022; 17(6):e0265465. PubMed ID: 35737644
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of mTOR and eIF4E expression in invasive ductal carcinoma.
Hu A; Sun M; Yan D; Chen K
Tumori; 2014; 100(5):541-6. PubMed ID: 25343550
[TBL] [Abstract][Full Text] [Related]
11. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
Salehi Z; Mashayekhi F
Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
[TBL] [Abstract][Full Text] [Related]
12. miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer.
Liu F; Wang X; Li J; Gu K; Lv L; Zhang S; Che D; Cao J; Jin S; Yu Y
Cell Prolif; 2015 Oct; 48(5):582-92. PubMed ID: 26250586
[TBL] [Abstract][Full Text] [Related]
13. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
[TBL] [Abstract][Full Text] [Related]
14. Expression profile of eukaryotic translation initiation factor and matrix metalloproteinase 9 in endometrial cancer tissue.
Shi ZM; Liu YN; Fu B; Shen YF; Li LM
J Biol Regul Homeost Agents; 2017; 31(4):1053-1059. PubMed ID: 29254314
[TBL] [Abstract][Full Text] [Related]
15. MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus.
Hsu HS; Chen HW; Kao CL; Wu ML; Li AF; Cheng TH
Ann Surg Oncol; 2011 May; 18(5):1469-77. PubMed ID: 21080085
[TBL] [Abstract][Full Text] [Related]
16. [Expression and its clinical significance of SHP2 in non-small cell lung cancer].
Tang C; Zhou X; Yang H; Wang Q; Zhang R
Zhongguo Fei Ai Za Zhi; 2010 Feb; 13(2):98-101. PubMed ID: 20673499
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.
Gao M; Zhang X; Li D; He P; Tian W; Zeng B
Oncotarget; 2016 Dec; 7(51):85502-85514. PubMed ID: 27907907
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical value of eukaryotic initiation factor 4E and matrix metalloproteinase-9 in supraglottic and hypopharyngeal carcinoma and metastasis lymph].
Sun S; Liu Q; Zhang A; He E
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Dec; 20(24):1116-9. PubMed ID: 17357517
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of eukaryotic initiation factor 4E is correlated with increased risk for systemic dissemination in node-positive breast cancer patients.
Yin X; Kim RH; Sun G; Miller JK; Li BD
J Am Coll Surg; 2014 Apr; 218(4):663-71. PubMed ID: 24491247
[TBL] [Abstract][Full Text] [Related]
20. Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome.
Chen CN; Hsieh FJ; Cheng YM; Lee PH; Chang KJ
J Surg Oncol; 2004 Apr; 86(1):22-7. PubMed ID: 15048676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
